"A study to evaluate the efficacy of Madhuyashti,Khadira and Shankha Bhasma on Acidity "

" A Clinical Study to evaluate the efficacy of an Ayurvedic Formulation (Ayucid) in the management of Amlapitta w.s.r. Non-Ulcer Dyspepsia"

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2018/05/013941

Enrollment

Registered

2018-05-17

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Healthy

Interventions

Intervention1: Ayurvedic Formulation - Ayucid (Madhuyashti, Khadira and Shankha Bhasma): Madhuyashti 200 mg Khadira 150mg Shankha Bhasma 150 mg The drug was formulated in form of a capsule of 500 mg e

Eligibility

Inclusion criteria

Inclusion criteria: Patients ready to give written consent. Patients presenting with classical features of Amlapitta.

Exclusion criteria

Exclusion criteria: Patients not willing for trial or not ready to give written consent. Age- 70 years. Patients with IBS Patients using Aspirin or other NSAIDâ??s Patients having any malignancy, history of gastric surgery, Cardiac problems, Tuberculosis Alarming symptoms like weight loss, GI bleeding and any other serious ailment.

Design outcomes

Primary

Measure	Time frame
Ayurvedic formulation (Ayucid - Madhuyashti, khadira and Shankha Bhasma ) is quite effective in treating Amlapitta. Timepoint: After 30 days of taking regular medicine	—

Secondary

Measure	Time frame
Ayurvedic formulation (Ayucid - Madhuyashti, khadira and Shankha Bhasma)alleviates the sign and symptoms of AmlapittaTimepoint: After 30 days of taking regular medicine	—

Countries

India

Contacts

Public ContactDr Manu Verma

Rajiv Gandhi Govt.Post Graduate Ayurvedic College, Paprola

mehra_bl@rediffmail.com9418017615

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026